Lisinopril with Hydrochlorothiazide
- Product NDC
- 0143-1264
- 11-digit product format
- 001431264
- Labeler code
- 0143
- Product ID
- 0143-1264_4ac4e37f-7ce8-4ef8-a4ed-2b66a9b96713
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lisinopril and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA076265
- Marketing category
- ANDA
- Marketing start
- 2002-07-08
- Marketing end
- 2023-01-18
- Substance
- HYDROCHLOROTHIAZIDE; LISINOPRIL
- Active strength
- 25 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Increased Diuresis [PE], Thiazide Diuretic [EPC], Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE INGREDIENT | 0J48LPH2TH | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| LISINOPRIL | ACTIVE INGREDIENT | E7199S1YWR | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| LISINOPRIL | ACTIVE INGREDIENT | E7199S1YWR | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| HYDROCHLOROTHIAZIDE | ACTIVE MOIETY | 0J48LPH2TH | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| LISINOPRIL | ACTIVE MOIETY | E7199S1YWR | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| LISINOPRIL ANHYDROUS | ACTIVE MOIETY | 7Q3P4BS2FD | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| ANHYDROUS DIBASIC CALCIUM PHOSPHATE | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| CALCIUM PHOSPHATE, DIBASIC, ANHYDROUS | INACTIVE INGREDIENT | L11K75P92J | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| FD&C BLUE NO. 2 | INACTIVE INGREDIENT | L06K8R7DQK | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| FERRIC OXIDE RED | INACTIVE INGREDIENT | 1K09F3G675 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| MANNITOL | INACTIVE INGREDIENT | 3OWL53L36A | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [H.J. HARKINS COMPANY, INC.] | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LISINOPRIL WITH HYDROCHLOROTHIAZIDE (LISINOPRIL AND HYDROCHLOROTHIAZIDE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC] | 1 | |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0143-1264-01 | 00143126401 | 100 TABLET in 1 BOTTLE, PLASTIC (0143-1264-01) | 100 tablet | 2002-07-08 | 2023-01-18 | No | No | Current |
| 0143-1264-10 | 00143126410 | 1000 TABLET in 1 BOTTLE, PLASTIC (0143-1264-10) | 1000 tablet | 2002-07-08 | 2023-01-18 | No | No | Current |